CSV - Computer System Validation

4,162 views 46 slides Jul 24, 2021
Slide 1
Slide 1 of 46
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46

About This Presentation

This document covers most of the topics in the CSV like Importance of CVS, Why to perform CSV, Validation Deliverables, Part 11 and Annex 11 Diferences


Slide Content

COMPUTERIZED SYSTEM
VALIDATION
Prepared by: Jaya Krishna Gude
M.S. (Pharm.), NIPER.
+91-7981145133
1

Flow of Presentation
Importance of CSV
Introduction to CSV
GAMP5
Data Integrity
Part 11 and Annex 11
Prepared by: G. Jaya krishna 2

Why to focus more on CSV?
EverythingwasgoingwellbeforeFDAandotherregulatoryagency
startedfocusinginDataIntegrity
EverythinginHumanlifeandPharmaindustryisaboutIntegrity.
In2016,dataintegrityissuestriggeredmorethanonethirdofall
regulatoryactions
USFDAtookmaximumactionsagainstchina,Indialedthepackwhen
itcametonon-compliancereportsissuesbyEURegulators.
EuropeanOperationsofMajorDrugcompanieslikeGSK,Otuska,Teva
werefoundtohaveseriousNon-complianceconcerns.
Preparedby: G. Jaya krishna 3

Cont..
EverythingwasgoingwellbeforeFDAandotherregulatoryagency
startedfocusinginDataIntegrity
EverythinginHumanlifeandPharmaindustryisaboutIntegrity.
In2016,dataintegrityissuestriggeredmorethanonethirdofall
regulatoryactions
USFDAtookmaximumactionsagainstchina,Indialedthepackwhen
itcametonon-compliancereportsissuesbyEURegulators.
EuropeanOperationsofMajorDrugcompanieslikeGSK,Otuska,Teva
werefoundtohaveseriousNon-complianceconcerns.
Prepared by: G. Jaya krishna 4

Cont..
InTeva’sHungaryPlant,USFDAAuditorsfoundQualityRelated
documentsinawastebinandalsofoundthatlackofcontrolstoprevent
analystsfromdeletingdataforthestandalonesystems.
IntheUK,GSKsAPIplantrecalledmorethan425,000Bacroban
antibioticproductsafterreceivingasternwarningletterfromFDA
Regulatorsinjuly2016forCrossContamination.
Failuretotakecorrectiveactioninatimelymannercanresultinshutting
downmanufacturingfacilities,consentdecrees,andstifffinancial
penalties.
Theultimateresultcouldbelossofjobsandcompaniessuffering
economicinstabilitiesresultingindownsizingandpossiblyeventual
bankruptcy.
Prepared by: G. Jaya krishna 5

Cost of Non-Compliance
Cost of Non-compliance is 1000 times higher then the cost of compliance
Poor Record Integrity/ GxPNon-compliance will result in
FDA –483 Observation (WL)
Import Alert
Consent Decrease
Criminal Prosecution
In the case of Serious Deficiencies/Critical Findings actions may need to be
taken by inspectorate and EU authorities:
Prohibition of Supply
Batches withdrawn from the EU Market
Refusal of the granting of a marketing Authorization
Prepared by: G. Jaya krishna 6

What is Validation ??
EstablishingDocumentedEvidencethataprovidesahighdegreeof
assurancethataspecificprocesswillconsistentlyproduceaproduct
meetingitspredeterminedspecificationsandqualityattributes
Qualificationisanactorprocesstoassuresomethingcomplieswith
somecondition,standardorspecificrequirements
“Wequalifyasystemand/orequipmentandwevalidatea
process”
Ex:“Youwillqualifyanautoclave,whereasyouvalidatethesterilization
process”
Thetermqualificationisnormallyusedforequipment,utilitiesand
systems,andvalidationforprocess
Prepared by: G. Jaya krishna 7

Why to perform Validation ??
Validationispredicaterule,henceitismandatorytoperform
Computerizedsystemvalidation
Accordingto21CFRPart820.70(i)–Whencomputersorautomated
dataprocessingsystemsareusedaspartofproductionorthequality
systems,themanufacturershallvalidatecomputersoftwareforits
intendeduseaccordingtoanestablishedprotocol.Allsoftwarechanges
shallbevalidatedbeforeapprovalandissuance.Thesevalidation
activitiesandresultsshallbedocumented
Prepared by: G. Jaya krishna 8

Purpose of Validation
To prove that we did validation right and system works as intended, identify any
bugs by challenging the system. It increases the confidence level
The personnel involved in the validation are may no longer with the company to
explain to the auditors. Proof of good validation should be maintained till
retention (Documentation is most critical and has to be self explanatory)
Which Systems needs Validation:
All Automated Systems, Computer System which is used to Store, Monitor or
Control GXP Operation and Data needs validation. If system is controlled by the
computer –PLC and it is storing electronic data and electronic signature more
detailed validation needed.
Reduces risk and legal liability, Having the evidence that computer systems are
correct for their purpose and operating properly represents a good business
practice.
Prepared by: G. Jaya krishna 9

Computerized System Validation
AComputerizedsystemconsistsoftheSoftware,Hardwareandthenetworking
components,Personneltogetherwiththecontrolledfunctionsandthe
associateddocumentation
According to the Regulatory guidelines Computerized system validation is
stated as “ESTABLISHING DOCUMENT EVIDENCE .”
Ex: Automated manufacturing equipment, Quality control systems , equipment,
laboratory, clinical (or) manufacturing data base systems.
Prepared by: G. Jaya krishna 10

In general , a combination of hardware,
software , people , documents, inputs,
processing and outputs working together
software Hardware
Controlling process
Equipment
Operating Procedures and
Documentation
People and Training
COMPUTER SYSTEM
Prepared by: G. Jaya krishna 11

Computerized System Vs Computer System
ComputerizedSystem:Anyprogrammabledevicehavinghardware,
peripherals,software,procedures,users,interconnectionsandinputsfor
electronicprocessing&outputofinformationUsedforreportingorcontrol
ComputerSystem:Acomputersystemisasetofintegrateddevicesthatinput,
output,process,andstoredataandinformation.Computersystemsare
currentlybuiltaroundatleastonedigitalprocessingdevice.Therearefivemain
hardwarecomponentsinacomputersystem:Input,Processing,Storage,
OutputandCommunicationdevices.
Prepared by: G. Jaya krishna 12

Types of Validation:
If data are transferred to another data format or system , validation should
include checks that data are not altered in value and / or meaning during this
migration process. E.g. Paper based reports, Screen shots, Video etc….
Prospective Validation –The validation of a new system as it is developed or
The Validation conducted prior to the distribution of either a new product or
product made under a revised manufacturing process
RetrospectiveValidation–Theprocessofevaluatingacomputersystem
currentlyinoperationagainststandardvalidationpracticesandprocedures.The
evaluationdeterminesthereliability,accuracy,andcompletenessofasystem
(existingsystem)
Concurrent Validation –Validation Simultaneously with Production
Prepared by: G. Jaya krishna 13

4Q Validation Overview (Traditional Method)
DesignQualification(DQ)–Documentedevidencethatthedesignofthe
systemmeetsrequirements
InstallationQualification(IQ)–Systemhasbeeninstalledcorrectly
OperationalQualification(OQ)–SystemOperatesaccordingtothedesign
PerformanceQualification(PQ)–Systemmeetsdesigncriteriaandoperates
accordingtorequirement
Prepared by: G. Jaya krishna 14

GAMP5
GoodAutomatedManufacturingPractice,Foundedin1991.
InternationalSocietyforPharmaceuticalEngineering(ISPE)setsthe
guidelinesformanufacturersandthecurrentVersionisGAMP5.
GAMPdescribesasetofprinciplesandproceduresthathelpensure
thatpharmaceuticalSoftwarehaverequiredquality.
Computersystemvalidation(CSV)followingGAMPguidelinesrequire
usersandsupplierstoworktogethersothatresponsibilitiesregarding
thevalidationprocessareunderstood.
Prepared by: G. Jaya krishna 15

WhyGAMP5?
•Facilitates the interpretation of regulatory requirements.
•Establishes a common language and terminology.
•Promotes a system life cycle approach based on good practice.
•Clarifies roles and responsibilities.
•Focus attention on those computerized systems with most impact on patient
safety, product quality, and data integrity
•Avoid duplication of activities.
Prepared by: G. Jaya krishna 16

GAMP5 Key Concepts:
ProductandProcessunderstanding
LifecycleapproachwithinaQMS
ScalableLifeCycleActivities
Science-basedQualityRiskManagement
LeveragingSupplierInvolvement
Prepared by: G. Jaya krishna 17

Who plays validation role?
QA and Validation:
Author some major documents
Provide advice , training , auditing
Senior management for each group decides :
Which systems to buy or build
How much resources to make available
What risks are acceptable
Support groups (IT Infrastructures):
Maintain proper network environment
Troubleshooting and maintenance
Desktop and infrastructure control
Prepared by: G. Jaya krishna 18

Validation overview / Computerized system life
cycle:
Concept-Duringtheconceptphasetheregulatedcompanyconsidersopportunitiesto
automateoneormorebusinessprocessesbaseduponbusinessandbenefits.Atthis
phase,initialrequirementswillbedevelopedandpotentialsolutionsconsidered.Froman
initialunderstandingofscope,costsandbenefitsadecisionismadeonwhetherto
proceedtotheprojectphase.
Project-Theprojectphaseinvolvesplanning,supplierassessmentandselection,
variouslevelsofspecification,configurationandverificationleadingtoacceptanceand
releaseforoperation.Riskmanagementisappliedtoidentifyrisksandtoremoveor
reducethemtoanacceptablelevel.
Operation-Thisphaseisthelongestphaseandismanagedbytheuseofdefined,up
todate,operationalproceduresappliedbypersonnelwhohaveappropriatetraining,
education,andexperience.Maintainingcontrol(IncludingSecurity),fitnessforintended
useandcompliancearekeyaspects.Themanagementofchangesofdifferentimpact,
scopeandcomplexityisanimportantactivityduringthisphase.
Retirement-Thefinalphaseistheultimateretirementofthesystem.Itinvolves
decisionsaboutdataretention,migrationordestructionandthemanagementofthese
processes.
Prepared by: G. Jaya krishna
19

ValidationApproach
1.PLAN
Validation Activities
2.DEFINE
Requirements
3. SELECT
Vendors
4.DESIGN AND REVIEW
5. CONSTRUCT AND TEST
6.INSTALL
7.QUALIFY
8.EVALUATE
Computerized System
Prepared by: G. Jaya krishna 20

GAMP CATEGORY
Prepared by: G. Jaya krishna
21

GAMP Categories
The GAMP categories were originally introduced to provide an initial
assessment as to the validation requirements / deliverables, In GAMP 4 there
were five software categories. These have been revised in GAMP5 to four
categories as detailed below:
Category 1–Infrastructure software including operating systems, Database
Managers, etc.
Category 3–Non configurable software including, commercial off the shelf
software (COTS), Laboratory Instruments / Software.
Category 4–Configured software including, LIMS, SCADA, DCS, CDS, etc.
Category 5–Bespoke/Tailor-made software
Prepared by: G. Jaya krishna 22

Validation Deliverables based on GAMP Categories
Prepared by: G. Jaya krishna
23
Software
Category
Validation Deliverables
IRA URS SA VP FS/FRS FRA CS/DS IQ OQ PQ RTM VSR
Category 1  - - - - - --- -
Category 3  - - - - 
Category 4        
Category 5        

Validationdeliverables:
1. Initial Risk Assessment (IRA) or GxPDocument
2. User Requirement Specification (URS)
3. Vendor Assessment / Supplier Assessment (VA / SA)
4. Functional Requirement Specification (FRS/FS)
5. Configuration / Design Specification (CS / DS) / Design
Qualification (DQ) –( Hard ware, Server, Infra Structure details)
6. Validation Plan (VP)
7. Factory Acceptance Test (FAT)
8. Site Acceptance Test (SAT)
9. Functional Risk Assessment (FRA)
Prepared by: G. Jaya krishna
24

10. Installation Qualification (IQ)
11. Operational Qualification (OQ)
12. Performance Qualification (PQ)
13. Traceability Matrix (TM)
14. Validation Summary Report (VSR)
15. System Release Certificate or Software Release Note
Prepared by: G. Jaya krishna 25

Specification and Qualification Relationships
V-Life Cycle Model
URS
FRS
DS
VP
System Build
VSR
PQ
OQ
IQ
Verifies
Verifies
Verifies
IRA /GxP
Prepared by: G. Jaya krishna 26

THE VALIDATION PROCESS
Consists of five specific processes
Validation Master Plan
Project Plan
Installation Qualification
Operational Qualification
Performance Qualification
Prepared by: G. Jaya krishna 27

DataIntegrity:
Def: The Extent to which the data is complete, correct and accurate is
Called Data Integrity . (First used by Stan Woollen)
Acronym: ALCOA ++
A –Attributable
L –Legible
C –Contemporaneous
O –Original
A –Accurate
Complete
Correct
Enduring
Available
Prepared by: G. Jaya krishna
28

DataIntegrity:
Attributable The Identity of the person completing a record (Who, When, Why)
Legible
The data is readable, Understandable, Traceable, Permanent
allowing for a clear picture of the activities that occurred
Contemporaneous
The data is recorded at the time it is generated or observed (No
Back dating)
Original
Original Records must preserve data accuracy, completeness,
content and meaning. Data as the file or format in which it was
initially generated
Accurate
The data record must be accurate whether paper or electronic, it
must be exact, true and free from error (this might require a
second verification if necessary)
Prepared by: G. Jaya krishna
29

Cont..
Consistent
Consistent application of date and time stamps in the expected
sequence.
Complete
All Information needs to be maintained. Batch pass-fail, Re-
analyses carried out. (OOS, OOT)
Enduring
Medium used to record data should be permanent and not
temporary memory RAM.
Available
Available/Accessible for review / audit for the life time of the
record.
Prepared by: G. Jaya krishna 30

Common ALCOA ++ Issues
CommonPasswords/Passwordssharing
AuthorityControl
UserPrivileges–Lackofrolebasedaccesscontrol
Laboratorieshavefailedtoimplementtocontrolsoverdataand
unauthorizedaccess
DataBackupandRestoration
AuditTrail–NoaudittrailfunctionorDisabledaudittrailfunction
ManipulationofDate/Timestamps&Backdating
Prepared by: G. Jaya krishna 31

Data Integrity: Violation of 21 CRR Part
211 is also termed as Data Integrity
Part211.68(C)statesthattheautomatedequipmentusedfor
performancemustsatisfytherequirementsofanoperationbyone
person&checkingbyanotherperson.(Twolevelcheckshouldbe
there)
Part211.100and211.160requirethatcertainactivitiesbedocumented
atthetimeofperformance&thatlaboratorycontrolsbescientifically
sound(Contemporaneous)
Part211.188,211.194requirecompleteinformation-data-records
derivedfromalltestsperformed.(Complete)
Part211.180requirestruecopiesorotheraccuratereproductionsofthe
originalrecords.(Accurate)
Prepared by: G. Jaya krishna 32

EU Annex-11
Annex11ispartoftheEuropeanGMPGuidelinesanddefinesthetermsof
referenceforcomputerizedsystemsusedbyorganizationsinthe
pharmaceuticalindustry.
AppliestoallformsofcomputerizedsystemsusedaspartofaGMPregulated
activities.
Acomputerizedsystemisasetofsoftwareandhardwarecomponentswhich
togetherfulfilcertainfunctionalities.
Theapplicationshouldbevalidated.
ITinfrastructureshouldbequalified.
Whereacomputerizedsystemreplacesamanualoperations,thereshouldbe
toresultantdecreaseinproductqualityassurance.
Thereshouldbenoincreasesintheoverallriskoftheprocess.
Prepared by: G. Jaya krishna 33

EU Annex-11
1
RiskManagement
2
Personnel
3
SuppliersandServiceProviders
4
Validation
5
Data
6
AccuracyChecks
7
DataStorage
8
Printouts
9
AuditTrails
10
ChangeandConfigurationManagement
11
PeriodicEvaluation
12
Security
13
IncidentManagement
14
ElectronicSignatures
15
BatchRelease
16
BusinessContinuity
17
Archiving Prepared by: G. Jaya krishna
34

EU Annex-11-Overview
Allthepersonnelshouldhaveappropriatequalifications,levelof
accessanddefinedresponsibilitiestocarryouttheirassignedduties
andthereshouldbeclosecooperationamongtheindividuals
Riskmanagementshouldbeappliedthroughoutthelifelifecycleofthe
computerizedbyconsideringpatientsafety,dataintegrityandproduct
quality
Forcriticaldataenteredmanually,thereshouldbeanadditionalcheck
ontheaccuracyofthedata.
Considerationshouldbegivenbasedonriskassessment,tobuilding
intothecreationofarecordofallGMPrelevantchangesanddeletions
andreasonforchangeshallbecaptured
Integrityandaccuracyofbackupdataandtheabilitytorestorethedata
shouldbecheckedduringthevalidationandmonitoredperiodically
Prepared by: G. Jaya krishna
35

EU Annex-11-Overview
Theextentofsecuritycontrolsdependsonthecriticalityofthe
computerizedsystem
Physicalorlogicalcontrolsshouldrestrictaccesstocomputerized
systemtoauthorizedpersons
Whenacomputerizedsystemisusedforrecordingcertificationand
batchrelease,thesystemshouldallowonlyauthorizedpersonsto
certifythereleaseofbatches
Allincidents,notonlysystemfailuresanddataerrorsshouldbe
reportedandassessed
Therootcauseofacriticalincidentshouldbeidentifiedandshouldform
thebasisofcorrectiveandpreventiveactions
Prepared by: G. Jaya krishna 36

EU Annex-11-Overview
Anychangestoacomputerizedsystem,includingsystem
configurationsshouldonlybemadeinacontrolledmannerin
accordancewithadefinedprocedure
Fortheavailabilityofcomputerizedsystemssupportingcritical
processes,provisionsshouldbemadetoensurecontinuityofsupport
forthoseprocessesintheeventofasystembreakdown
Computerizedsystemsshouldbeperiodicallyevaluatedtoconfirmthat
theyremaininavalidstateandarecompliantwithGMPandsuch
evolutionsincludeDeviation,Upgrade,SecurityandValidationstatus
reports
Whenthirdpartiesareused,formalagreementsmustexistbetweenthe
partiesandtheseagreementsshouldincludeclearstatementsofthe
responsibilitiesofthethirdparty
Prepared by: G. Jaya krishna 37

EU Annex-11-Overview
TheValidationdocumentationandreportsshouldcovertherelevantsteps
ofthelifecycle.
Shouldbeabletojustifystandards,protocols,acceptancecriteria,
proceduresandrecordsbasedontheriskassessment.
UserRequirementsSpecificationsshoulddescribetherequiredfunctions
ofthecomputerizedsystemandbebasedondocumentedriskassessment
andGMPimpact.
Userrequirementsshouldbetraceablethroughoutthelife-cycle.
Forcriticalsystemsanup-to-datesystemdescriptiondetailingthephysical
andlogicalarrangements,dataflowandinterfaceswithothersystemsor
processes,anyhardwareandsoftwarepre-requisitesandsecurity
measuresshouldbeavailable.
Theregulatedusershouldtakeallreasonablestepstoensurethatthe
systemhasbeendevelopedinaccordancewithanappropriateQuality
ManagementSystem.
Prepared by: G. Jaya krishna
38

EU Annex-11-Overview
DocumentationsuppliedwithCommercial-off-the-shelfproductsshouldbe
reviewedbyregulateduserstocheckthatuserrequirementsarefulfilled.
Evidenceofappropriatetestmethodsandtestscenariosshouldbe
demonstrated.Particularly,systemparameterlimits,datalimitsanderror
handlingshouldbeconsidered.
ValidationdocumentationshouldincludeChangeControlrecordsandreports
onanydeviationsobservedduringthevalidationprocess.
Ifdataaretransferredtoanotherdataformatorsystem,validationshould
includechecksthatdataarenotalteredinvalueand/ormeaningduringthis
migrationprocess.
Computerizedsystemsexchangedataelectronicallywithothersystemsshould
includeappropriatebuilt-inchecksforthecorrectandsecureentryand
processingofdata,inordertominimizetherisks.
Prepared by: G. Jaya krishna 39

21 CFR Part 11-Background
21CFRPart11isalawthatensurescompaniesimplementgoodbusiness
practices.
21CFR(CodeofFederalRegulations)Part11hasdefinedbytheUSFDA
regulationsthatsetforththecriteriaappliestoelectronicrecordsandelectronic
signaturesthatpersonscreate,modify,maintain,archive,retrieve,ortransmit
underanyrecordsorsignaturerequirementsetforthintheFederalFood,Drug,
andCosmeticAct,thePublicHealthServiceAct,oranyFDAregulation
Part11allowsacompanytoimplementcomputersystemsthatwillgreatly
increasetheefficiencyofindividuals,reduceerrorsbyidentifyingrisks,and
increaseoverallproductivityofthecompany.
InMarch1997,FDAissuedfinalPart11regulationsthatprovidecriteriafor
acceptancebyFDA,undercertaincircumstances,ofelectronicrecords,
electronicsignatures,andhandwrittensignaturesexecutedtoelectronic
recordsasequivalenttopaperrecordsandhandwrittensignaturesexecutedon
paper.
Prepared by: G. Jaya krishna 40

21 CFR Part 11-Background
Electronicsignaturesthatareintendedtobetheequivalentof
handwrittensignatures,initials,andothergeneralsigningsrequiredby
predicaterules.
Theseregulations,whichapplytoallFDAprogramareas,were
intendedtopermitthewidestpossibleuseofelectronictechnology,
compatiblewithFDA'sresponsibilitytoprotectthepublichealth.
Part11signaturesincludeelectronicsignaturesthatareused,for
example,todocumentthefactthatcertaineventsoractionsoccurredin
accordance withthepredicaterule(e.g.approved,
reviewed,andverified).
Prepared by: G. Jaya krishna 41

21 CFR Part 11-ERES Contents
Subpart A: General Provisions
•11.1 Scope
•11.2 Implementation
•11.3 Definitions
Subpart B. Electronic Records
•11.10 Controls for Closed Systems
•11.30 Controls for Open Systems
•11.50 Signature Manifestations
•11.70 Signature/Record Linking
Subpart C: Electronic Signatures
•11.100 General Requirements
•11.200 (a) Controls and Components for Non-Biometrics
•11.200 (b) Controls and Components for Biometrics
•11.300 Identification of Codes and Passwords
Prepared by: G. Jaya krishna
42

21 CFR Part 11-Overview
Validationofsystemstoensureaccuracy,reliability,consistent,intended
performanceandtheabilitytodiscerninvalidoralteredrecords
Theabilitytogenerateaccurateandcompletecopiesofrecordsinbothhuman
readableandelectronicformsuitableforreview,inspection
Protectionofrecordstoenabletheiraccurateandreadyretrievalthroughoutthe
recordsretentionperiod
Limitingsystemaccesstoauthorizedindividuals.Uniquecombinationofuser
nameandpassword
Useofsecure,computer-generated,time-stampedaudittrailstoindependently
recordthedate&timeofoperatorentriesandactionsthatcreate,modifyor
deleteelectronicrecords
Useofoperationalsystemcheckstoenforcepermittedsequencingofsteps&
eventsasappropriate
Prepared by: G. Jaya krishna 43

21 CFR Part 11-Overview
Authorizedindividualscanonlyusethesystemandcanelectronicallysigna
record
Thepersonswhodevelop.Maintain,useER/ESsystemsshallhavethe
Education,TrainingandExperiencetoperformtheirassignedtasks
Theindividualsareaccountableandresponsiblefortheactionsinitiatedunder
theirelectronicsignatures
SignatureManifestationitmusthaveDateandtime,completenameofsigner
andMeaningofsignature
EachElectronicsignatureshallbeuniquetooneindividualandshallnotbe
reused,reassignedtoanyoneotherthantheoriginaluser
ShouldverifytheidentityofanindividualbeforeassigningElectronicsignature
Prepared by: G. Jaya krishna 44

21 CFR Part 11-Overview
Theelectronicsignaturesareintendedtobethelegallybindingequivalentof
traditionalhandwrittensignatures
Electronicsignaturenotbasedonbiometricsshallhavetwodistinguished
componentssuchasIdentificationcode(username)andpasswordandtheir
combinationshouldbeunique(Notwoindividualscanhavethesame
combination)
ProceduresshallbeinplaceforPasswordperiodicchecking,De-authorization
ofpasswords,invalidattempts.
Systemshalllockoutonconsecutiveunsuccessfulattempts(Invalidattempts)
Systemshallhaveautologoutprovision
Prepared by: G. Jaya krishna 45

G. Jaya Krishna
46